You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous serum 20%

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Milano (intralesional rituximab, supplemental autologous

Completed
  • Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
  • intralesional rituximab
  • supplemental autologous serum
  • Milano, Italy
    Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 2, 2022

Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)

Completed
  • Corneal Epithelial Defect
  • Amniotic membrane transplantation
  • Autologous serum/BSS 20%
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Nov 21, 2021

PRP Trial in Prishtina (PRP plasma rich platelets, Autologous serum)

Enrolling by invitation
  • PRP
  • PRP plasma rich platelets
  • Autologous serum
  • Prishtina, Kosovo
    Eye Hospital,University Center Clinic of Kosova
Jul 6, 2023

Corneal Epithelial Wound Trial in Banha, BaNHA (Insulin, autologous serum (AS), conventional)

Not yet recruiting
  • Corneal Epithelial Wound
  • Banha, Kalyobeya, Egypt
  • +1 more
Apr 15, 2022

Corneal Cells of Groth Factor-enriched Plasma and Autologous

Recruiting
  • Aniridia
  • Peripheral venous blood sample
  • Conjunctival impression
  • Paris, France
    Hôpital Fondation A. de Rothschild
Dec 6, 2022

Ulcer Venous Trial in Turin (Autologous extracellular vesicles from serum)

Recruiting
  • Ulcer Venous
  • Autologous extracellular vesicles from serum
  • Turin, Italy
    AOU San Giovanni Battista
May 18, 2022

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal

Completed
  • Sjogren's Syndrome
  • +2 more
  • Autologous serum tears combined with 0.05% cyclosporin eye drop
  • Chengdu, Sichuan, China
    Hospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023

Keratoconus, Keratoconus of Right Eye, Keratoconus, Unstable, Right Eye Trial in Pristina (Fresh corneal lenticule and

Active, not recruiting
  • Keratoconus
  • +2 more
  • Fresh corneal lenticule and autologous serum in advanced keratoconus using ReLex Smile surgery
  • Pristina, Kosovo
    Eye Hospital Pristina
Jul 25, 2022

Periodontitis Trial in Rize (biochemical analysis)

Completed
  • Periodontitis
  • biochemical analysis
  • Rize, Turkey
    Recep Tayyip Erdogan University
Oct 18, 2023

Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy

Recruiting
  • Neuropathy Associated With Dysproteinaemias
  • no intervention
  • Tekirdağ, Turkey
    Tekirdag Namik Kemal University
Nov 15, 2022

Dry Eye Syndromes, Sjogren Syndrome With Keratoconjunctivitis Trial in El Palomar (Amniotic membrane extract eye drops (AMEED))

Completed
  • Dry Eye Syndromes
  • Sjogren Syndrome With Keratoconjunctivitis
  • Amniotic membrane extract eye drops (AMEED)
  • El Palomar, Buenos Aires, Argentina
  • +2 more
Oct 24, 2022

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Aug 10, 2022

Adenoviral Keratoconjunctivitis Trial in Pristina (relex smile)

Active, not recruiting
  • Adenoviral Keratoconjunctivitis
  • relex smile
  • Pristina, Kosovo
    Eye Hospital Pristina
Nov 13, 2021

Covid19, Influenza A, Influenza B Trial in San Nicolás De Los Garza (Vitamine D3 supplementation, Diet and sun exposure)

Terminated
  • Covid19
  • +3 more
  • Vitamine D3 supplementation
  • Diet and sun exposure
  • San Nicolás De Los Garza, Nuevo León, Mexico
    Hospital Clinica Nova de Monterrey
Apr 7, 2022

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in Milwaukee (CAR-20/19-T cells (1.0 x10^5

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +3 more
  • CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Jun 26, 2022

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Dry Eye Disease Trial in Ratchathewi (100% Autologous platelet rich plasma, 100% Autologous serum)

Recruiting
  • Dry Eye Disease
  • 100% Autologous platelet rich plasma
  • 100% Autologous serum
  • Ratchathewi, Bangkok, Thailand
    Ophthalmology Department, Ramathibodi Hospital
Feb 24, 2021

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
  • +4 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Sep 22, 2022

Spinal Stenosis Lumbar, Spinal Canal Stenosis Trial in Warszawa (combination product, drug, procedure)

Active, not recruiting
  • Spinal Stenosis Lumbar
  • Spinal Canal Stenosis
  • Goldic serum
  • +2 more
  • Warszawa, Mazovia, Poland
    Sutherland Medical Center
Mar 10, 2021

Shock, Systemic Inflammatory Response Syndrome (SIRS), Hypoalbuminaemia Trial in Strasbourg (Human serum albumin infusion 4%,

Terminated
  • Shock
  • +2 more
  • Human serum albumin infusion 4%
  • Human serum albumin infusion 20%
  • Strasbourg, France
    Hôpitaux Universitaire de Strasbourg
Sep 13, 2021

19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

Recruiting
  • 19 and 22+ B Cell Hematologic Tumors
  • 19 and 20+ B Cell Hematologic Tumors
  • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
  • Wuhan, Hubei, China
    Tongji Hospital
Jan 11, 2023